The molecular mechanism of desensitization of soluble guanylyl cyclase (sGC), the NO receptor, has long remained unresolved. Posttranslational modification and redox state have been postulated to affect sGC sensitivity to NO but evidence has been lacking. We now show that sGC can be S-nitrosylated in primary aortic smooth muscle cells by S-nitrosocysteine (CSNO), an S-nitrosylating agent, in human umbilical vein endothelial cells after vascular endothelial growth factor treatment and in isolated aorta after sustained exposure to acetylcholine. Importantly, we show that S-nitrosylation of sGC results in decreased responsiveness to NO characterized by loss of NO-stimulated sGC activity. Desensitization of sGC is concentration-and time-dependent on exposure to CSNO, and sensitivity of sGC to NO can be restored and its S-nitrosylation prevented with cellular increase of thiols. We confirm in vitro with semipurified sGC that S-nitrosylation directly causes desensitization, suggesting that other cellular factors are not required. Two potential S-nitrosylated cysteines in the ␣-and ␤-subunits of sGC were identified by MS. Replacement of these cysteines, C243 in ␣ and C122 in ␤, created mutants that were mostly resistant to desensitization. Structural analysis of the region near ␤-C122 in the homologous Nostoc H-NOX crystal structure indicates that this residue is in the vicinity of the heme and its S-nitrosylation could dampen NO activation by affecting the positions of key residues interacting with the heme. This study suggests that S-nitrosylation of sGC is a means by which memory of NO exposure is kept in smooth muscle cells and could be a mechanism of NO tolerance.
I
n the cardiovascular system, nitric oxide (NO) is critical for regulation of vascular tone and homeostasis (1, 2) . In mammals, the main sensor of NO is the soluble guanylyl cyclase (sGC), a heme-containing heterodimer formed by an ␣-and a ␤-subunit. When NO binds to the heme, catalytic activity of sGC increases several hundredfold to produce the second messenger cGMP (3) . Despite the importance of the NO-cGMP pathway in the biology and pathology of the cardiovascular and neuronal systems, modulation of sGC is poorly understood (4, 5) . In particular, the mechanism of desensitization of sGC has remained unresolved despite 30 years of effort. Desensitization is the transition to a state in which sGC's response to a new NO stimulation is reduced or abolished. This direct effect on sGC differs from the desensitization of the NO-cGMP pathway caused by decrease in cGMP levels [e.g., because of increased phosphodiesterase activity (6) ] or decrease in NO availability (7) . Desensitization of sGC itself has been reported in various cell types and tissues after exposure to NO (8-11) but its mechanism is unknown. Ser/Thr phosphorylation was proposed to be involved but evidence is still lacking (12) , and Tyr phosphorylation was ruled out recently (13) . Elucidating the mechanism of sGC desensitization is crucial considering its likely involvement in NO tolerance during the development of oxidative vascular pathophysiologies, atherosclerosis, and pulmonary hypertension.
S-nitrosylation, a NO-dependent posttranslational modification of free-thiol cysteines, alters the function of many proteins, including enzymes (14) , and is proposed to be involved in the physiologies and pathophysiologies of the cardiovascular system (15) . We reasoned that sGC, as the main, if not only, receptor activated by NO, could be targeted by S-nitrosylation to induce its desensitization, thus constituting an exquisite process of sGC modulation by negative feedback. We tested the hypothesis that sGC desensitization is induced by S-nitrosylation.
Results sGC Is S-Nitrosylated in Primary Aortic Smooth Muscle Cells (SMC)
Treated with S-Nitrosocysteine (CSNO). To investigate Snitrosylation of sGC, we used primary aortic SMC because the function and importance of the NO-cGMP pathway is well defined in this system: vasorelaxation is induced in vivo by NO produced by the endothelial cells layer, which diffuses into the underlying SMC where it activates sGC. SMC were treated for 1h with CSNO at 1 mM or L-cysteine (L-Cys; 1 mM) as control. CSNO has been used extensively as an S-nitrosylating agent in intact cells (16) . After washout, S-nitrosylation of endogenous sGC in the cytosolic fraction was assessed by the biotin switch assay (17) followed by avidin purification and coimmunoprecipitation using anti-SNO antibodies as described (16, 18) . Western blot analysis with anti-sGC antibodies (Fig. 1A) showed, with both methods, that cytosolic sGC is S-nitrosylated in cells treated with CSNO but not in cells treated with L-Cys. In addition, the reciprocal immunoprecipitation, using anti-sGC antibodies followed by biotin switch assay and avidin purification showed that only the cytosols from CSNO-treated cells contained S-nitrosylated sGC [supporting information (SI) Fig. 6 ]. In parallel, we confirmed the capacity of S-nitrosoglutathione (GSNO) to S-nitrosylate sGC in cytosols and the specificity of detection of SONO bond by the biotin switch assay using ascorbate, which can generate thiols from S-nitrosothiol but not from other S-oxidized thiols (SI Fig. 7 ) (19) .
sGC Is S-Nitrosylated in Human Umbilical Vein Endothelial Cells (HUVEC) Treated with Vascular Endothelial Growth Factor (VEGF).
We demonstrated that sGC S-nitrosylation takes place under more physiological conditions. HUVEC, which express both endothelial NO synthase and sGC were treated with VEGF, which induces NO production (20) . One-hour treatment with 10 ng/ml of VEGF resulted in S-nitrosylation of sGC, whereas Snitrosylated sGC could not be detected in untreated cells. In addition to showing that sGC is S-nitrosylated by an endogenous modulator, this result shows that sGC is not ''constitutively'' S-nitrosylated in these cells (Fig. 1B) . For further studies only primary aortic SMC were used because the levels of sGC activity are much higher than in HUVEC.
sGC Is S-Nitrosylated in Freshly Isolated Aorta Treated with Acetylcholine (Ach). To determine whether sGC in SMC could be S-nitrosylated from a physiological source of NO, rat aorta were isolated and treated with 100 M Ach for 1 h (controls were untreated aorta). After removal of the endothelial layer, homogenates were prepared and S-nitrosylation was assayed by a biotin-switch assay coupled to avidin purification. Western blot with anti-sGC (Fig. 1C) shows that S-nitrosylated sGC was readily detected in the aorta treated with Ach but not in the untreated aorta (Fig. 1C Right) , whereas the amount of sGC was similar in untreated and treated samples (Fig. 1C Left) .
sGC Is Desensitized in SMC Treated with CSNO. The cytosols of SMC prepared above were assayed for basal and NO-stimulated sGC activity [using S-nitro-N-acetyl-penicillamine (SNAP) at 1 and 100 M as the NO donor]. Fig. 1D shows that cytosols prepared from cells treated with 1 mM CSNO did not respond to NO stimulation, whereas the basal activity was similar to the basal activity of cytosols treated with L-Cys. As expected, the NOstimulated sGC activity of L-Cys-treated cytosols increases with increasing concentrations of SNAP. This result strongly suggested a correlation between sGC S-nitrosylation and loss of NO sensitivity.
S-Nitrosylation and Desensitization of sGC Are Time-and ConcentrationDependent. To determine the extent of correlation between S-nitrosylation and desensitization, SMC were treated with two different concentrations of CSNO (100 M and 1 mM) for two periods (15 min and 1 h); L-Cys was used as a control. As shown in Fig. 2A , the S-nitrosylation levels of sGC increased as a function of time and concentration of CSNO. One hour of exposure to 100 M CSNO readily produced sGC Snitrosylation. The time of exposure could be shortened to 15 min with 1 mM CSNO. Using 1 mM of L-Cys for 1 h did not lead to detectable S-nitrosylation. Importantly, these increased levels of S-nitrosylation were directly paralleled by increased desensitization (shown in Fig. 2B ). In addition, desensitization of sGC as a function of time and concentration of CSNO was directly assessed in intact cells by measuring the cGMP production in response to SNAP at 100 M by RIA (for this, the sGC activity per se is not measured but the cGMP accumulation during 1h treatment with SNAP). The results were similar, showing that the NO-stimulated cGMP production was reduced as a function of time and CSNO concentration (SI Table 1 ).
S-Nitrosylation and Desensitization of sGC Can Be Blocked in SMC.
S-nitrosylation is a reversible posttranslational modification dependent on the redox state of the cells (21) . To assess the specificity and correlation between sGC S-nitrosylation and desensitization, SMC were pretreated with N-acetyl-cysteine (NAC), a physiological precursor of glutathione (GSH) (22) . Before CSNO and L-Cys treatment of SMC (1 h, 250 M), 2.5 mM of NAC was applied for 2 h. As shown in Fig. 2C , pretreatment with NAC prevented CSNO-induced S-nitrosylation, as the amount of sGC pulled down by anti-SNO in the precleared cytosols was greatly reduced. No sGC was pulled down by anti-SNO after L-Cys or L-Cys ϩ NAC treatment, as expected (Fig. 2C Left) . In addition, the presence of sGC in the supernatant of the immunoprecipitated cytosols (i.e., non-S-nitrosylated sGC) was verified: higher amounts of sGC were detectable in the L-Cys, L-Cys ϩ NAC, and CSNO ϩ NAC samples than in the CSNO samples, confirming that NAC reduced S-nitrosylation of sGC and suggesting that the proportion of CSNO-dependent S-nitrosylated sGC was high (Fig. 2C Right) . Importantly, sensitivity to NO of the sGC was restored in the cytosols treated with CSNO if they were pretreated with NAC, compared with cytosols from cells not pretreated with NAC ( Fig.  2D ; 304 Ϯ 14 vs. 522 Ϯ 34 pmol/min per mg). Indeed, the NO-stimulated sGC activity was similar in the cytosols from the cells treated with NAC ϩ CSNO and NAC ϩ L-Cys. As above, basal activity was similar under all conditions. The fact that increasing intracellular free thiols can block desensitization of sGC to NO and
Biotin -Avidin its S-nitrosylation strongly suggests that desensitization of sGC is linked to its S-nitrosylation in cells.
S-Nitrosylation Directly Induces Desensitization of Semipurified sGC.
To determine whether S-nitrosylation directly causes desensitization of sGC or other cellular factors are required, we induced S-nitrosylation of semipurified sGC (stored without DTT, GSH, or glycerol). sGC was pretreated with 50 M GSNO in the dark for 10 min (the SONO bonds are light sensitive, which probably explains why desensitization of sGC was not observed before, when GSNO was used as a NO donor). After incubation, the sGC/GSNO mix was diluted 100-fold in reaction buffer. and the basal and NO-stimulated sGC activities were measured. Fig. 3A shows that GSNO pretreatment compared with GSH reduced by Ϸ50% the sGC activity stimulated with a saturating concentration of SNAP (100 M). A biotin switch assay (Fig. 3B ) confirms that sGC is S-nitrosylated by GSNO but not by GSH. The basal activity of sGC was increased by pretreatment with GSNO (167 Ϯ 13 and 571 Ϯ 59 nmol⅐min Ϫ1 ⅐mg Ϫ1 for GSH and GSNO pretreatment, respectively), as 0.5 M GSNO is still present in the mix after dilution.
Cys-243 in the ␣-Subunit (␣C243) and Cys-122 in the ␤-subunit (␤C122) of sGC Are S-Nitrosylated, as Determined by MS and Are Involved in sGC Desensitization. Bovine sGC was subjected to the biotin switch assay followed by in-solution tryptic digest. After separation of the peptides by RPLC, potential biotinylated peptides (m/z consistent with biotinylation of tryptic peptides of sGC) were identified. Among them, the MS/MS spectra of two peptides with m/z 1,232.88 and 1,079.68 Da were acquired and confirmed to correspond to FHQDCR of the ␣1-subunit and CTDADK of the ␤1-subunit, which contain C245 (bovine sequence) and C122, respectively (Fig. 4) . The two corresponding Cys in rat sGC were replaced by Ala, and the resulting mutants were expressed transiently in COS-7 cells. COS-7 overexpressing WT (␣1/␤1), ␣1C243A/␤1, and ␣1/␤1C122A were treated with 250 M CSNO or L-Cys for 1 h. Cytosols were prepared as above and sGC activity was measured in response to NO stimulation (SNAP, 100 M). As shown in Fig. 5A , whereas pretreatment with CSNO decreased NO-stimulated activity of the WT to 46.4 Ϯ 1.5% compared with L-Cys treatment (100%), the NO response of ␣1C243A/␤1 was only slightly decreased (to 84.3 Ϯ 3.0%), which corresponds to elimination of Ϸ70% of the desensitization. It is worth noting that mutation ␣1C243A did not affect NO-stimulated sGC activity per se, as the specific activity for the WT and ␣1C243A/␤1 after 1 mM L-Cys treatment were 3,144 Ϯ 46 and 3,025 Ϯ 114 pmol/min per mg, respectively. Mutant ␣1/␤1C122A also lost part of its NO-dependent desensitization; 71.3% Ϯ 4.1% of activity remaining, which corresponds to elimination of Ϸ45% of the desensitization (its NO-stimulated sGC was Ϸ3-fold lower: 959.4 Ϯ 107.8 pmol/min per mg). We also assayed the double-mutant ␣1C243A/ ␤1C122A, which had activity similar to ␣1/␤1C122A and was apparently more sensitive to desensitization (Ϸ65% of NOstimulated activity remaining; data not shown). Identical results were obtained when, instead of SNAP, diethylamine-NO (100 M) was used, suggesting that the source of NO for stimulation of sGC did not play a role.
Structural Modeling of the C122 S-Nitroso Form of H-NOX Domain.
A structural model was generated for the C122 S-nitroso form of H-NOX domain from our recently solved apo and liganded form of Ns H-NOX (23), which is closely related to the heme binding domain of sGC␤1 (Fig. 5B) . Residue C122 is conserved in both sGC and Ns H-NOX and is located in a conserved hydrophobic region. The C122 in the Ns H-NOX is located in the protein interior and its S atom has Ͻ1 Å of solvent-accessible areas as calculated with MSCON (24) . The buried nature of C122 is consistent with that of the Cys residues that are nitrosylated in tubulin (25) and thioredoxin (26) . The buried, nitrosylated C62 in thioredoxin, which is oriented toward the protein interior, thus serves as a prototype for modeling S-nitroso-C122 in H-NOX. The model suggests three potential structural changes after S-nitroso modification of C122. The S-nitrosylation group increases the length of this side chain by Ϸ2.5 Å, which would likely cause shifts in either C122 or neighboring residues because the S atom of C122 is already in close van der Waals distance with M98, M130, and L132 (all within 4.1 Å). The latter two residues are adjacent to the Y134xS136xR138 heme propionate interaction sequence, whose position could be altered by nitrosylation of C122, thus affecting signal transduction via spaceaccommodating shifts in M130 (L in sGC␤1) and L132 (conserved in sGC␤1). The S atom of C122 is also proximate to the CB atom of M98 (L in sGC␤1), which is part of the helix harboring the heme proximal ligand H105. A potential shift of this helix and altered positioning of H105 upon C122 Snitrosylation could hamper NO activation. Alternatively, C122 itself could be pushed out of the normal position upon Snitrosylation, which could affect NO activation because C122 is located on the ␤-strand containing residue F120 (conserved in sGC␤1), which forms Ϸ4-Å van der Waals interactions with the heme.
Discussion
In the present study, we investigated whether S-nitrosylation of sGC, the receptor for NO, is the molecular mechanism that leads to desensitization/tolerance to NO. We hypothesized that Snitrosylation of sGC could be responsible, simply because sGC The heme is shown in stick mode. The helix containing M98 and H105, the strands containing C122 and F120 and M130, L132, and Y134 are shown in cartoon mode, and the remaining residues are in coil representation. The NO group is in ball mode and was modeled according to the S-nitrosylated C62 residue from thioredoxin. The image was generated by using PYMOL (www.pymol.org).
is the main receptor for NO and as such could be the primary target of NO signaling negative feedback. To determine whether sGC was S-nitrosylated, we treated primary aortic SMC, which express high levels of sGC, with CSNO, a physiological Snitrosothiol found in plasma and transported into cells via L-Cys transporters (27, 28) . Using three methods (immunoprecipitation with anti-SNO or anti-sGC and the biotin switch assay followed by avidin purification), we established that sGC is S-nitrosylated in intact SMC. This was confirmed under more physiological conditions by treating HUVEC that express both endothelial NO-synthase and sGC (at low levels) with VEGF and importantly, by subjecting rat aorta to sustained physiological NO exposure via treatment with Ach. We next demonstrated that CSNO-induced S-nitrosylation correlates with desensitization of sGC in SMC and that desensitization and S-nitrosylation were time-and concentration-dependent and could be prevented by increasing intracellular thiols with NAC. These results suggest that the stability of sGC S-nitrosylation and response to NO depends on the cellular redox state.
S-nitrosylation by GSNO causes directly desensitization in vitro with semipurified sGC. To investigate further the mechanism of desensitization, we conducted a MS analysis of sGC S-nitrosylation and identified at least two Cys that were targets of S-nitrosylation in vitro. We showed that ␣1C243 and ␤1C122 are involved in the desensitization mechanism of sGC in cells, as their replacement conferred resistance to desensitization in COS-7 cells treated with CSNO. Importantly, the replacement of ␣1C243 with Ala did not affect the NO-stimulated sGC activity but specifically blunted NO desensitization. Interestingly, preliminary study with the double mutant indicated that it was 35% desensitized after CSNO treatment (compared with Ϸ15% and 28% for ␣1C243A and ␤1C122A, respectively). One possible explanation for the lack of ''additive'' effect of both mutations is a compensatory mechanism in which other Cys are Snitrosylated. Information regarding the structural changes induced by S-nitrosylation is still limited. To our knowledge, the only examples observed by x-ray crystallography are from hemoglobin (29) and thioredoxin (26) . Our modeling of the C122 S-nitroso form of the heme domain predicts a shift of the helix carrying the His-105 that ligates the heme, or a change in the positioning of F120, which is located on the same ␤ strand as C122 and interacts with the heme, or altering the interaction with L132, which is adjacent to the heme propionate interaction. Each of these modifications would alter NO activation.
␤1C122A is widely conserved but ␣1C243A is conserved only in mammalian species, in which development of desensitization/ vascular tolerance is observed. Interestingly, C243 was proposed to be part of a regulatory binding site for BAY 41-2772 (NOindependent activator) (30) but this observation was not supported by site-directed mutagenesis (31) . As part of a mutational analysis of conserved Cys residues, Cys-78 and Cys-214 in the ␤1-subunit were mutated but the lost of NO-stimulated activity of the corresponding mutants was caused by heme depletion (32) . It has been suggested that Cys could be involved in modulation of sGC via formation of disulfide bond. Recently, it was shown that treatment of bovine pulmonary arteries with diamide, which oxidizes sulfhydryl groups, inhibited NOstimulated sGC activity (33) , yet the Cys residues potentially involved in this process remain unidentified.
The sustained stimulation of NO production in aortas treated with Ach led to sGC S-nitrosylation, which supports the observation that high NO concentration in the presence of O 2 led to N 2 O 3 formation (34), the in vivo quintessential S-nitrosylating agent. Moreover, oxidative stress is often associated with the formation of reactive nitrogen species such as peroxynitrite, formed by the reaction of endogenous NO with superoxide, which decreases NO-stimulated sGC activity (35) and N 2 O 3 (36) . Taken together, our results support the idea that prolonged NO exposure reduces sGC activity caused by redox modulation of thiols (33) . Thus, it is tempting to speculate that S-nitrosylation of sGC is the missing link between NO tolerance and oxidative stress in the development of cardiovascular oxidative pathologies.
Among the many mechanisms of receptor desensitization (phosphorylation, internalization, translocation, or proteinprotein interaction), this study provides evidence that the mechanism of desensitization of sGC, the NO receptor, can take place via S-nitrosylation. The idea that the NO-cGMP pathway is modulated by S-nitrosylation is indirectly supported by the fact that sGC is not endogenously S-nitrosylated in HUVEC or isolated aorta unless exposed to VEGF or Ach, respectively. Moreover, colocalization of the NO source and its target likely contributes to selective S-nitrosylation (14) , and sGC is associated with NO synthase in a multiprotein complex probably involving Hsp90 and PSD95 (37, 38) . If S-nitrosylation of sGC leads to desensitization, thereby altering NO-dependent vasodilation (for example), then dysfunction of sGC modulation could constitute a crucial element in the development of cardiovascular diseases, as we have revealed a link between Snitrosylation of sGC and blunted response to NO. Isolation and Ach Treatment of Rat Aorta. Ring segments of thoracic aorta were cleaned and placed in a physiologic buffer (130 mM NaCl/5.6 mM KCl/2 mM CaCl 2 /1 mM MgCl 2 /11 mM glucose/10 mM Hepes, pH 7.4) at 37°C and then stimulated with 100 M Ach for 1 h, followed by denudation of the endothelium. The aortas were then snap-frozen before homogenization in 50 mM Hepes, 150 mM NaCl, 1 mM DTT, 10% glycerol, 1 mM EDTA, and protease inhibitors containing buffer. Soluble fraction was collected by centrifugation. All procedures were approved by the Institutional Animal Care and Use Committee of New Jersey Medical School.
Methods
Site-Directed Mutagenesis and Transfection. Templates were cDNAs encoding the ␣1-and ␤1-subunits of rat sGC cloned into the mammalian expression vector pCMV5. The ␣1C243A and ␤1C122A mutations were introduced by PCR (Quikchange; Stratagene, La Jolla, CA) and checked by DNA sequencing. COS-7 cells were transfected for 48 h with HyFect reagent, according to the supplier's protocol (Denville, South Plainfield NJ).
Cytosol Preparation and Immunoprecipitation. Rat aortic SMC were grown to passages 4-6 in 100-mm dishes and after various treatments were washed twice with ice-cold PBS, scraped off the plate in cold lysis buffer (50 mM Hepes, pH 8.0/1 mM EDTA/150 mM NaCl/protease inhibitors). After sonication, the lysate was centrifuged at 16,000 ϫ g for 10 min at 4°C to collect the soluble Statistical Analysis. Data are expressed as mean Ϯ SE. For sGC activity, each experiment was done with two to three independent batches of SMC or transfections in COS-7 cells. Coimmunoprecipitation and biotin/avidin assay were repeated at least three times. Comparison of sGC activities between pretreatment with L-Cys and CSNO or between treatment with CSNO and CSNO ϩ NAC were made with Student's t test by using SigmaPlot version 8.0 software (Systat Software, San Jose, CA). P Ͻ 0.05 was considered statistically significant.
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